A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Zacks Rank 3-Hold, Recommend Neutral, Industry Rank 90 / 265, Target 12.40, Avg target of 11 analyst 26.88
- Short Interest Ratio: 4.47
- Est Revision Ratio: Up 1 vs 32 Down
close position on a rise to 10.744 (i.e. +0.6%)